Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben Granich

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|July 27, 2017
90-90-90 and ending AIDS: necessary and feasibleReuben Granich, Brian Williams, Julio Montaner, et al.
The Lancet. Public Health|December 19, 2017
Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling studyBrian G Williams, Somya Gupta, Matthew Wollmers, et al.
The Lancet. Infectious Diseases|September 5, 2003
Tuberculosis control in IndiaReuben Granich, Fraser Wares, Sahu Suvanand, et al.
The Lancet. HIV|August 27, 2016
The impact and cost of ending AIDS in BotswanaBrian G Williams, Somya Gupta, Matt Wollmers, et al.
Bulletin of the World Health Organization|March 17, 2012
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisAmitabh B Suthar, Reuben Granich, Jonathan Mermin, et al.
Journal of the International Association of Providers of AIDS Care|June 6, 2014
Global Policy Review of Recommendations on Cotrimoxazole Prophylaxis among People Living with HIVSomya Gupta, Reuben Granich, Bradley Hersh, et al.
Journal of the International Association of Providers of AIDS Care|December 31, 2015
Pattern, Determinants, and Impact of HIV Spending on Care and Treatment in 38 High-Burden Low- and Middle-Income CountriesReuben Granich, Somya Gupta, Julio Montaner, et al.
AIDS Research and Treatment|May 22, 2012
Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenyaReuben Granich, Nicolas Muraguri, Alexandre Doyen, et al.
The Lancet. Infectious Diseases|October 31, 2015
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulationAnthony D Harries, Stephen D Lawn, Amitabh B Suthar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
Prevention of tuberculosis in people living with HIVReuben Granich, Christopher Akolo, Christian Gunneberg, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|July 27, 2017
90-90-90 and ending AIDS: necessary and feasibleReuben Granich, Brian Williams, Julio Montaner, et al.
The Lancet. Public Health|December 19, 2017
Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling studyBrian G Williams, Somya Gupta, Matthew Wollmers, et al.
The Lancet. Infectious Diseases|September 5, 2003
Tuberculosis control in IndiaReuben Granich, Fraser Wares, Sahu Suvanand, et al.
The Lancet. HIV|August 27, 2016
The impact and cost of ending AIDS in BotswanaBrian G Williams, Somya Gupta, Matt Wollmers, et al.
Bulletin of the World Health Organization|March 17, 2012
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisAmitabh B Suthar, Reuben Granich, Jonathan Mermin, et al.
Journal of the International Association of Providers of AIDS Care|June 6, 2014
Global Policy Review of Recommendations on Cotrimoxazole Prophylaxis among People Living with HIVSomya Gupta, Reuben Granich, Bradley Hersh, et al.
Journal of the International Association of Providers of AIDS Care|December 31, 2015
Pattern, Determinants, and Impact of HIV Spending on Care and Treatment in 38 High-Burden Low- and Middle-Income CountriesReuben Granich, Somya Gupta, Julio Montaner, et al.
AIDS Research and Treatment|May 22, 2012
Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenyaReuben Granich, Nicolas Muraguri, Alexandre Doyen, et al.
The Lancet. Infectious Diseases|October 31, 2015
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulationAnthony D Harries, Stephen D Lawn, Amitabh B Suthar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
Prevention of tuberculosis in people living with HIVReuben Granich, Christopher Akolo, Christian Gunneberg, et al.
Pageof 8